moricizine has been researched along with Arrhythmia in 113 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 54 (47.79) | 18.7374 |
1990's | 59 (52.21) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sanna, GP | 1 |
Kubanov, RD; Liakishev, AA; Mazur, NA | 1 |
Duff, HJ; Oates, JA; Roden, DM; Woosley, RL | 1 |
Kurbanov, RD; Mazur, NA; Piotrovskiĭ, VK | 1 |
Rozenshtraukh, LV; Shevchenko, NM; Shugushev, KhKh; Smetnev, AS | 1 |
Lewis, RA; Mason, DT; Miller, RR; Pratt, CM; Quinones, MA; Taylor, AA; Yepsen, SC | 1 |
Rozenshtraukh, LV; Shugushev, KhKh; Smetnev, AS | 1 |
English, L; Francis, MJ; Kopelen, H; Mann, DE; Norton, HJ; Pratt, CM; Quinones, MA; Roberts, R; Taylor, AA; Young, JB | 1 |
DiBianco, R; Fletcher, RD; Ginsberg, R; Gottdiener, JS; Singh, SN | 1 |
Horvat, M; Jakopin, J; Kenda, MF; Rakovec, P; Rode, P | 1 |
Rosen, MR; Wit, AL | 1 |
Rossi, L | 1 |
Luck, JC; Mann, DE; Pratt, CM; Wyndham, CR | 1 |
Grigor'eva, EK; Kaverina, NV; Lyskovtsev, VV; Senova, ZP | 1 |
Benchimol, A; Desser, KB | 1 |
Harrison, DC; Kates, RE; Keefe, DL | 1 |
Kaverina, NV; Rozenshtraukh, LV; Shugushev, KhKh; Smetnev, AS | 1 |
Aniukhovskiĭ, EP; Beloshapko, GG; Dremin, SA; Kaverina, EP; Rozenshtraukh, LV | 1 |
Aniukhovskiĭ, EP; Beloshapko, GG; Dremin, SA; Rozenshtraukh, LV | 1 |
Anyukhovsky, EP; Beloshapko, GG; Bugrij, EM; Kuzmin, AV; Makielski, JC; Mazaev, AV; Nesterenko, VV; Rosenshtraukh, LV; Starmer, CF | 1 |
Dolgopiatova, M; Giardina, EG; Sciacca, R; Wechsler, ME | 1 |
Anderson, JL; Carlson, M; Davies, R; Duff, HJ; Greene, HL; Hallstrom, AP; Huther, M; Kammerling, JM; Romhilt, DW | 1 |
Bhandari, AK; Cannom, DS; Ehrlich, S; Leon, C; Lerman, R; Sager, P; Widerhorn, J | 1 |
DeMaria, A; Gottlieb, S; Greene, HL; Hallstrom, A; Huther, M; Pratt, CM; Young, JB | 1 |
Brooks, MM; Campion, J; Gorkin, L; Ledingham, RB; Schron, EB; Wiklund, I | 1 |
Anderson, JL; Buckingham, TA; Carlson, MD; Carson, PE; Hallstrom, A; Henthorn, RW; Platia, EV | 1 |
Guo, WY; Jiang, WD; Li, ZS; Yang, JM; Zhu, JR | 1 |
Anderson, JL; Capone, RJ; Cohen, JD; Epstein, AE; Hallstrom, AP; Liebson, PR; Rogers, WJ; Seals, AA; Wyse, DG | 1 |
Barker, AH; Brooks, MM; Capone, R; Echt, DS; Greene, HL; Liebson, PR; Mitchell, LB; Peters, RW | 1 |
Brooks, MM; Gorkin, L; Kellen, J; Morris, M; Pawitan, Y; Schoenberger, JA; Schron, EB; Shumaker, S; Verter, J; Wiklund, I | 1 |
Bartashevich, VV; Galenko-Iaroshevskiĭ, PA; Kanorskiĭ, SG; Khankoeva, AI; Skibitskiĭ, VV; Uvarov, AV | 1 |
Dougherty, AH; Naccarelli, GV; Wiggins, S; Wolbrette, D | 1 |
Chang, C; Clarkson, CW; Liu, W; Pickoff, AS; Stolfi, A; Yamasaki, S | 1 |
Tonkin, AM | 1 |
Lastra, AA; Nesterenko, VV; Rosenshtraukh, LV; Starmer, CF | 1 |
Kanorskiĭ, SG; Petrova, TR; Skibitskiĭ, VV | 1 |
Li, CL; Xie, JT | 2 |
Kaverina, NV; Sokolov, SF | 1 |
Greene, HL; Henthorn, RW; Katz, RJ; Roden, DM; Salerno, DM; Woosley, RL | 1 |
Hashimoto, K; He, ZS; Komori, S; Tamura, K | 1 |
Dunn, SL | 1 |
Akiyama, T; Barker, AH; Campbell, WB; Friedman, L; Josephson, RA; Keller, M; Papa, L; Pawitan, Y; Rubbert, P | 1 |
Clyne, CA; Estes, NA; Wang, PJ | 1 |
Borland, RM; Greatrix, B; Mahler, S; Podrid, P; Pratt, CM | 1 |
Morganroth, J | 3 |
Pratt, CM | 1 |
Akhtar, M; Breithardt, G; Camm, AJ; Coumel, P; Janse, MJ; Lazzara, R; Myerburg, RJ; Schwartz, PJ; Waldo, AL; Wellens, HJ | 1 |
Somberg, J | 2 |
Brooks, R; Damle, R; Frumkin, W; Goldberger, J; Greenberg, S; Kadish, AH; Levine, J; Matos, J | 1 |
Brooks, R; Garan, H; Gold, MR; McGovern, BA; Powell, AC; Ruskin, JN | 1 |
Podrid, PJ | 2 |
Kerin, NZ | 1 |
Grigor'eva, ZE; Stepanova, IV; Vizir, AD; Vizir, VA | 1 |
Guo, W; Zhu, J | 1 |
Bigger, JT; Epstein, AE; Hallstrom, AP; Reynolds-Haertle, RA; Romhilt, DW; Wyse, DG | 1 |
Cohen, JD; Hallstrom, A; Mahmarian, J; McBride, R; Steinberg, JS; Wyse, DG | 1 |
Greene, HL; Hallstrom, AP; Huther, ML | 1 |
Vaughan Williams, EM | 1 |
Grubb, BP | 1 |
Kurbanov, RD | 1 |
Bigger, JT | 3 |
Anderson, JL | 1 |
Buckley, MT; Fitton, A | 1 |
Mann, HJ | 1 |
Bigger, JT; Morganroth, J | 1 |
Borland, RM; Mahler, SA | 1 |
Barbey, JT; Schwartz, SL; Siddoway, LA; Woosley, RL | 1 |
Beau, SL; Podrid, PJ | 1 |
Blum, RI; Buckingham, TA; Kennedy, HL; Redd, RM; Sprague, MK; Wiens, RD | 1 |
Ponamarenko, EL; Rozenshtraukh, LV; Shugushev, KhKh; Smetnev, AS | 1 |
Koltunova, MI; Ponomarenko, EL; Shugushev, KhKh; Smetnev, AS | 1 |
Abdalla, A; Mazur, NA | 1 |
Chekhov, AM; Gimrikh, EO; Pekarskiĭ, VV; Popov, SV; Savenkov, GG | 1 |
Snyder, DW | 1 |
Camm, AJ; Garratt, C; Ward, DE | 1 |
Mukharliamov, NM; Ponomarenko, EL; Rozenshtraukh, LV; Shugushev, KhKh; Smetnev, AS | 1 |
Morganroth, J; Pratt, CM | 1 |
Buckingham, TA; Homan, SM; Janosik, DL; Kennedy, HL; Redd, RM; Seiler, SM; Sprague, MK; Wiens, RD | 1 |
Engel, T; Kelliher, GJ; Kowey, P; Wetstein, L | 1 |
Fang, WH | 1 |
Huang, SK; Marcus, FI | 1 |
Garson, A; Moak, JP; Smith, RT | 1 |
Kiiakbaev, GK; Kurbanov, RD | 1 |
Glezer, MG; Kurbanova, ZIu | 1 |
Asinger, RW; Granrud, GA; Hodges, M; Salerno, DM; Sharkey, PJ | 1 |
Baker, BJ; Kennedy, HL; Mason, DT; Morganroth, J; Platt, ML; Pratt, CM; Singh, SN | 1 |
Butman, SM; English, LD; Knoll, M; Pratt, CM; Young, JB | 1 |
Hession, MJ; Lampert, S; Lown, B; Podrid, PJ | 1 |
Hession, M; Lampert, S; Lown, B; Podrid, PJ; Pratt, CM; Quiñones, M; Seals, AA; Young, JB | 1 |
Mádle, A | 1 |
Borland, RM; Leon, CA; Pratt, CM; Quinones, MA; Raizner, A; Roberts, R; Seals, AA; Wierman, AM; Young, JB | 1 |
Gorbachev, VV; Mrochek, AG; Odinets, VS; Pristrom, MS; Sytyĭ, VP | 1 |
Berdiaev, SIu; Darinskiĭ, NV; Kaverina, NV; Kelemen, K; Marko, R | 1 |
Rosenshtraukh, LV; Shugushev, KK; Smetnev, AS | 1 |
Golitsyn, SP; Malakhov, VI; Smetnev, AS; Sokolov, SF | 1 |
Berdiaev, SIu; Darinskiĭ, NV; Kaverina, NV; Rodionov, AP; Shestakova, NV | 1 |
Ageev, FT; Mareev, VIu | 1 |
Delclos, G; Leon, CA; Mahler, SA; Pratt, CM; Quinones, MA; Roberts, R; Seals, AA; Wierman, AM; Young, JB | 1 |
24 review(s) available for moricizine and Arrhythmia
Article | Year |
---|---|
Electropharmacology of antiarrhythmic drugs.
Topics: Action Potentials; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Electric Conductivity; Heart Atria; Heart Ventricles; Humans; Lidocaine; Membrane Potentials; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Procainamide; Propranolol; Purkinje Fibers; Quinidine; Tocainide; Verapamil | 1983 |
Investigational antiarrhythmic drugs for the treatment of ventricular rhythm disturbances.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Encainide; Flecainide; Humans; Imipramine; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Tocainide | 1984 |
New antiarrhythmic drugs: their place in therapy.
Topics: Action Potentials; Ajmaline; Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bretylium Tosylate; Disopyramide; Encainide; Hemodynamics; Humans; Kinetics; Moricizine; Morpholines; Phenothiazines; Piperidines; Verapamil | 1981 |
Treatment of ventricular arrhythmias after CAST.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Death, Sudden, Cardiac; Electrocardiography, Ambulatory; Encainide; Flecainide; Heart Ventricles; Humans; Moricizine; Myocardial Infarction; Ventricular Function, Left | 1992 |
Pharmacology and clinical use of a new group of antiarrhythmic drugs: derivatives of tricyclic nitrogen-containing systems.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Brain; Cell Membrane; Dibenzazepines; Hemodynamics; Moricizine; Phenothiazines | 1992 |
Moricizine.
Topics: Arrhythmias, Cardiac; Heart; Humans; Moricizine | 1992 |
CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Double-Blind Method; Encainide; Flecainide; Humans; Moricizine; Multicenter Studies as Topic; Phenothiazines; Randomized Controlled Trials as Topic | 1990 |
[Advances in the research on moricizine and its uses in anti-arrhythmia].
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Moricizine | 1991 |
Moricizine: a new agent for the treatment of ventricular arrhythmias.
Topics: Arrhythmias, Cardiac; Heart Ventricles; Humans; Moricizine | 1991 |
[Comparative characteristics of arrhythmogenic effects of anti-arrhythmia agents].
Topics: Aconitine; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Electrocardiography; Humans; Moricizine; Phenothiazines; Procainamide; Propranolol | 1991 |
Comparisons of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Double-Blind Method; Encainide; Female; Flecainide; Humans; Male; Moricizine; Phenothiazines; Propranolol; Quinidine; Randomized Controlled Trials as Topic | 1990 |
Moricizine. A review of its pharmacological properties, and therapeutic efficacy in cardiac arrhythmias.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Moricizine; Phenothiazines | 1990 |
Moricizine: a new class I antiarrhythmic.
Topics: Arrhythmias, Cardiac; Drug Interactions; Humans; Moricizine | 1990 |
Cardiac electrophysiologic effects of moricizine hydrochloride.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Clinical Trials as Topic; Dose-Response Relationship, Drug; Electrocardiography, Ambulatory; Electrophysiology; Female; Heart Conduction System; Humans; Male; Moricizine; Phenothiazines; United States; USSR | 1990 |
Clinical development of moricizine as an antiarrhythmic agent.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Electrocardiography, Ambulatory; Humans; Moricizine; Phenothiazines; Randomized Controlled Trials as Topic; United States; USSR | 1990 |
Clinical pharmacokinetics of moricizine.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cimetidine; Clinical Trials as Topic; Digoxin; Drug Interactions; Humans; Moricizine; Phenothiazines; Propranolol; Theophylline; Warfarin | 1990 |
Antiarrhythmic drug therapy for congestive heart failure with focus on moricizine.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Heart Failure; Hemodynamics; Humans; Moricizine; Phenothiazines; Stroke Volume | 1990 |
Class IB antiarrhythmic drugs: tocainide, mexiletine, and moricizine.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Tocainide | 1989 |
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil | 1985 |
Clinical pharmacology of antiarrhythmic agents.
Topics: Adrenergic beta-Antagonists; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Calcium Channel Blockers; Electrophysiology; Encainide; Flecainide; Heart Conduction System; Humans; Lidocaine; Moricizine; Phenothiazines; Piperidines; Quaternary Ammonium Compounds; Sotalol; Tocainide | 1985 |
Antiarrhythmic drug therapy of ventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Sotalol; Tocainide; Verapamil | 1986 |
Efficacy and tolerance of Ethmozine (moricizine HCl) in placebo-controlled trials.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Drug Administration Schedule; Humans; Moricizine; Phenothiazines; Placebos | 1987 |
[Electrophysiological mechanisms of the anti-arrhythmia action of ethacizin].
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrioventricular Node; Electrocardiography; Humans; Moricizine; Phenothiazines; Sinoatrial Node | 1986 |
Antiarrhythmic drug therapy (Part 2). Benefits and hazards.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Propafenone; Propiophenones; Tocainide | 1985 |
47 trial(s) available for moricizine and Arrhythmia
Article | Year |
---|---|
[Experience in the clinical use of etmozin in different cardiac rhythm disturbances].
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Dose-Response Relationship, Drug; Electrocardiography; Heart Rate; Humans; Middle Aged; Moricizine; Morpholines; Phenothiazines; Time Factors | 1980 |
Selection of an antiarrhythmic drug for a sudden-death-prevention trial.
Topics: Acecainide; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bretylium Compounds; Clinical Trials as Topic; Death, Sudden; Encainide; Flecainide; Humans; Kinetics; Lidocaine; Mexiletine; Moricizine; Morpholines; Phenothiazines; Piperidines; Tocainide; Verapamil | 1982 |
[Effect of a new anti-arrhythmia preparation ethacizin (a diethylamine analog of ethmozin) on the heart conduction system in different forms of heart rhythm disorder].
Topics: Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrioventricular Node; Bundle of His; Clinical Trials as Topic; Female; Heart Conduction System; Heart Function Tests; Humans; Male; Middle Aged; Moricizine; Phenothiazines; Purkinje Fibers | 1983 |
Ethmozine suppression of single and repetitive ventricular premature depolarizations during therapy: documentation of efficacy and long-term safety.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Echocardiography; Electrocardiography; Female; Humans; Male; Middle Aged; Moricizine; Phenothiazines; Tachycardia | 1983 |
Comparative effect of disopyramide and ethmozine in suppressing complex ventricular arrhythmias by use of a double-blind, placebo-controlled, longitudinal crossover design.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyramide; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Moricizine; Phenothiazines | 1984 |
Effect of moricizine hydrochloride in reducing chronic high-frequency ventricular arrhythmia: results of a prospective, controlled trial.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chronic Disease; Clinical Trials as Topic; Echocardiography; Electrocardiography; Exercise Test; Heart; Humans; Male; Middle Aged; Moricizine; Phenothiazines; Prospective Studies | 1984 |
Combination ethacizin and ethmozin treatment of resistant ventricular ectopy: theoretical, experimental, and clinical study.
Topics: Adult; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Computer Simulation; Dogs; Drug Therapy, Combination; Electric Stimulation; Electrocardiography; Female; Heart Conduction System; Heart Rate; Heart Ventricles; Humans; Male; Middle Aged; Models, Biological; Moricizine; Receptors, Drug; Sodium Channels | 1994 |
Moricizine concentration to guide arrhythmia treatment: with attention to elderly patients.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Electrocardiography; Female; Half-Life; Humans; Male; Middle Aged; Moricizine; Prospective Studies; Tachycardia, Ventricular | 1994 |
Time to arrhythmic, ischemic, and heart failure events: exploratory analyses to elucidate mechanisms of adverse drug effects in the Cardiac Arrhythmia Suppression Trial.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Double-Blind Method; Encainide; Flecainide; Heart Failure; Humans; Moricizine; Myocardial Infarction; Myocardial Ischemia; Risk Factors; Survival Analysis; Time Factors | 1995 |
Relations between heart failure, ejection fraction, arrhythmia suppression and mortality: analysis of the Cardiac Arrhythmia Suppression Trial.
Topics: Arrhythmias, Cardiac; Electrocardiography; Encainide; Female; Flecainide; Heart Failure; Humans; Male; Middle Aged; Moricizine; Multivariate Analysis; Myocardial Infarction; Predictive Value of Tests; Prognosis; Prospective Studies; Regression Analysis; Stroke Volume; Survival Analysis | 1995 |
Moricizine and quality of life in the Cardiac Arrhythmia Suppression Trial II (CAST II).
Topics: Aged; Arrhythmias, Cardiac; Female; Heart Ventricles; Humans; Male; Middle Aged; Moricizine; Placebo Effect; Placebos; Prospective Studies; Quality of Life; Surveys and Questionnaires; Treatment Outcome | 1994 |
Interaction of baseline characteristics with the hazard of encainide, flecainide, and moricizine therapy in patients with myocardial infarction. A possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST).
Topics: Arrhythmias, Cardiac; Encainide; Female; Flecainide; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction; Statistics as Topic; Survival Analysis | 1994 |
Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST).
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Female; Flecainide; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction; Survival Analysis; Ventricular Function, Left | 1993 |
Circadian pattern of arrhythmic death in patients receiving encainide, flecainide or moricizine in the Cardiac Arrhythmia Suppression Trial (CAST).
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Aspirin; Circadian Rhythm; Death, Sudden, Cardiac; Double-Blind Method; Encainide; Flecainide; Heart Arrest; Humans; Moricizine; Sympathetic Nervous System | 1994 |
Psychosocial predictors of mortality in the Cardiac Arrhythmia Suppression Trial-1 (CAST-1).
Topics: Arrhythmias, Cardiac; Chi-Square Distribution; Encainide; Flecainide; Humans; Moricizine; Myocardial Infarction; Prognosis; Psychological Tests; Psychology, Social; Regression Analysis; Social Support | 1993 |
Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction.
Topics: Arrhythmias, Cardiac; Cardiac Complexes, Premature; Female; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction; Survival Rate | 1992 |
[Comparative analysis of antiarrhythmic action and electrophysiological effects of a new benzodiazepine derivative gidazepam and ethacizin in arrhythmias of various genesis].
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzodiazepines; Benzodiazepinones; Cardiac Pacing, Artificial; Electrocardiography, Ambulatory; Electrophysiology; Female; Humans; Male; Middle Aged; Moricizine; Psychotropic Drugs; Time Factors | 1992 |
The Cardiac Arrhythmia Suppression Trial: first CAST ... then CAST-II.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Double-Blind Method; Encainide; Flecainide; Humans; Moricizine; Myocardial Infarction; Survival Rate | 1992 |
Effects of advancing age on the efficacy and side effects of antiarrhythmic drugs in post-myocardial infarction patients with ventricular arrhythmias. The CAST Investigators.
Topics: Adult; Age Factors; Aged; Aging; Arrhythmias, Cardiac; Drug Therapy, Combination; Encainide; Flecainide; Follow-Up Studies; Humans; Logistic Models; Middle Aged; Moricizine; Myocardial Infarction; Prognosis; Stroke Volume | 1992 |
Dose effect of moricizine on suppression of ventricular arrhythmias.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography, Ambulatory; Humans; Moricizine; Phenothiazines; Tachycardia; Time Factors | 1990 |
Proarrhythmic potential of moricizine: strengths and limitations of a data base analysis.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Encainide; Flecainide; Humans; Information Systems; Moricizine; Phenothiazines; Tachycardia | 1990 |
CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Double-Blind Method; Encainide; Flecainide; Humans; Moricizine; Multicenter Studies as Topic; Phenothiazines; Randomized Controlled Trials as Topic | 1990 |
Events in the Cardiac Arrhythmia Suppression Trial (CAST): mortality in the entire population enrolled.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Double-Blind Method; Encainide; Female; Flecainide; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction | 1991 |
Events in the Cardiac Arrhythmia Suppression Trial (CAST): mortality in patients surviving open label titration but not randomized to double-blind therapy.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Female; Flecainide; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction; Regression Analysis | 1991 |
CAST II stopped after deaths.
Topics: Arrhythmias, Cardiac; Humans; Moricizine; Risk | 1991 |
The events surrounding the removal of encainide and flecainide from the Cardiac Arrhythmia Suppression Trial (CAST) and why CAST is continuing with moricizine.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Flecainide; Humans; Mass Media; Moricizine; National Institutes of Health (U.S.); Phenothiazines; Randomized Controlled Trials as Topic; United States; United States Food and Drug Administration | 1990 |
Implications of the Cardiac Arrhythmia Suppression Trial for antiarrhythmic drug treatment.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Double-Blind Method; Encainide; Europe; Flecainide; Humans; Moricizine; Multicenter Studies as Topic; Phenothiazines; Randomized Controlled Trials as Topic; Research Design; United States; United States Food and Drug Administration | 1990 |
Comparisons of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Double-Blind Method; Encainide; Female; Flecainide; Humans; Male; Moricizine; Phenothiazines; Propranolol; Quinidine; Randomized Controlled Trials as Topic | 1990 |
CAST and beyond. Implications of the cardiac arrhythmia suppression trials. By the Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Double-Blind Method; Encainide; Flecainide; Humans; Moricizine; Multicenter Studies as Topic; Phenothiazines; Randomized Controlled Trials as Topic | 1990 |
Cardiac electrophysiologic effects of moricizine hydrochloride.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Clinical Trials as Topic; Dose-Response Relationship, Drug; Electrocardiography, Ambulatory; Electrophysiology; Female; Heart Conduction System; Humans; Male; Moricizine; Phenothiazines; United States; USSR | 1990 |
Clinical development of moricizine as an antiarrhythmic agent.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Electrocardiography, Ambulatory; Humans; Moricizine; Phenothiazines; Randomized Controlled Trials as Topic; United States; USSR | 1990 |
Clinical pharmacokinetics of moricizine.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cimetidine; Clinical Trials as Topic; Digoxin; Drug Interactions; Humans; Moricizine; Phenothiazines; Propranolol; Theophylline; Warfarin | 1990 |
Antiarrhythmic drug therapy for congestive heart failure with focus on moricizine.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Heart Failure; Hemodynamics; Humans; Moricizine; Phenothiazines; Stroke Volume | 1990 |
Serum digoxin concentrations during ethmozine antiarrhythmic therapy.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Complexes, Premature; Clinical Trials as Topic; Digoxin; Drug Interactions; Female; Heart Failure; Humans; Kinetics; Male; Middle Aged; Moricizine; Phenothiazines | 1986 |
Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.
Topics: Aged; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Death, Sudden; Encainide; Female; Flecainide; Follow-Up Studies; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction; Phenothiazines; Random Allocation | 1989 |
Lessons from the cardiac arrhythmia suppression trial.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Encainide; Flecainide; Humans; Moricizine; Myocardial Infarction; Phenothiazines; United States | 1989 |
[Initial results of clinical research on a tabletted form of ethacizin (the diethylamino analog of ethmozine) in ventricular arrhythmias].
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Dose-Response Relationship, Drug; Electrocardiography; Exercise Test; Female; Humans; Male; Middle Aged; Moricizine; Phenothiazines; Tablets; Time Factors | 1985 |
Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Encainide; Female; Flecainide; Heart Failure; Humans; Imipramine; Male; Middle Aged; Moricizine; Myocardial Infarction; Phenothiazines; Random Allocation; Stroke Volume | 1988 |
Efficacy, safety, hemodynamic effects, and pharmacokinetics of high-dose moricizine during short- and long-term therapy.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Electrocardiography; Female; Hemodynamics; Humans; Kinetics; Male; Middle Aged; Moricizine; Phenothiazines | 1987 |
Efficacy and tolerance of Ethmozine (moricizine HCl) in placebo-controlled trials.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Drug Administration Schedule; Humans; Moricizine; Phenothiazines; Placebos | 1987 |
Antiarrhythmic efficacy of Ethmozine (moricizine HCl) compared with disopyramide and propranolol.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyramide; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Moricizine; Phenothiazines; Propranolol; Random Allocation | 1987 |
Effects of Ethmozine (moricizine HCl) on ventricular function using echocardiographic, hemodynamic and radionuclide assessments.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Echocardiography; Exercise Test; Female; Heart; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Moricizine; Phenothiazines; Prospective Studies; Radionuclide Imaging | 1987 |
Complex ventricular arrhythmias associated with the mitral valve prolapse syndrome. Effectiveness of moricizine (Ethmozine) in patients resistant to conventional antiarrhythmics.
Topics: Adult; Aged; Arrhythmias, Cardiac; Death, Sudden; Drug Resistance; Echocardiography; Female; Humans; Male; Middle Aged; Mitral Valve Prolapse; Moricizine; Phenothiazines; Syndrome | 1986 |
[Double-blind research on the anti-arrhythmia effect of ethacizin].
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Moricizine; Phenothiazines | 1986 |
Ethacizin: a new efficacious Soviet antiarrhythmic drug of the phenothiazine group.
Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Electrocardiography; Female; Humans; Male; Middle Aged; Monitoring, Physiologic; Moricizine; Phenothiazines | 1986 |
[Hemodynamic effect of ethmozine and its diethylamine analog ethacizin on central hemodynamics in patients with various functional states of the myocardium].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Clinical Trials as Topic; Heart Failure; Heart Rate; Hemodynamics; Humans; Middle Aged; Moricizine; Myocardial Contraction; Phenothiazines | 1985 |
Safety and efficacy of a twice-daily dosing regimen for moricizine (ethmozine).
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Administration Schedule; Humans; Moricizine; Phenothiazines; Research Design | 1985 |
49 other study(ies) available for moricizine and Arrhythmia
Article | Year |
---|---|
New drugs in the management of ventricular arrhythmias.
Topics: Acecainide; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bretylium Compounds; Drug Interactions; Encainide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Propafenone; Propiophenones; Tocainide | 1984 |
[Pharmacodynamics and the pharmacokinetic parameters of etmozin in ventricular heart rhythm disorders].
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Female; Heart Ventricles; Humans; Kinetics; Male; Middle Aged; Moricizine; Phenothiazines; Tachycardia, Paroxysmal; Time Factors | 1982 |
[The effect of a new anti-arrhythmia agent, a diethylamine analog of ethmozine, on the electrophysiological indices of the sinoatrial node in patients with its normal function and dysfunction].
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electric Stimulation; Electrocardiography; Female; Humans; Male; Middle Aged; Moricizine; Myocardial Contraction; Phenothiazines; Sinoatrial Node | 1983 |
Electrophysiological effects of ethmozin on sinus nodal function in patients with and without sinus node dysfunction.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Moricizine; Phenothiazines; Sick Sinus Syndrome; Sinoatrial Node | 1984 |
Nursing care for survivors of sudden cardiac death.
Topics: Adaptation, Psychological; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Arrest; Heart Conduction System; Humans; Lidocaine; Mexiletine; Moricizine; Nursing Assessment; Phenothiazines; Tocainide | 1984 |
[Ethacizin: pharmacologic properties and prospects for clinical application].
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cats; Coronary Circulation; Coronary Disease; Dogs; Electrocardiography; Heart Rate; Humans; Moricizine; Myocardial Infarction; Phenothiazines; Rabbits; Rats; Tachycardia | 1984 |
New drugs for treating cardiac arrhythmias.
Topics: Acebutolol; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Encainide; Heart Ventricles; Humans; Mexiletine; Moricizine; Morpholines; Phenothiazines; Tocainide; Verapamil | 1981 |
[First clinical application of a new Soviet anti-arrhythmia preparation, a diethylamine derivative of ethmozin, in patients with various disorders of cardiac rhythm].
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Blood Pressure; Drug Evaluation; Electrocardiography; Female; Humans; Male; Middle Aged; Moricizine; Phenothiazines | 1982 |
[Effect of the diethylamine analog of etmozin on myocardial function (a clinical and experimental study)].
Topics: Action Potentials; Adult; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Dogs; Drug Evaluation; Drug Evaluation, Preclinical; Female; Heart; Heart Conduction System; Heart Rate; Humans; In Vitro Techniques; Male; Middle Aged; Moricizine; Myocardial Contraction; Phenothiazines | 1982 |
[Effect of the diethylamine analog of etmozin and cesium chloride on the idioventricular rhythm in dogs in the late stages of experimental myocardial infarct].
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cesium; Chlorides; Dogs; Female; Male; Moricizine; Myocardial Infarction; Phenothiazines; Sinoatrial Node | 1981 |
Electrophysiological evaluation of moricizine in patients with sustained ventricular tachyarrhythmias: low efficacy and high incidence of proarrhythmia.
Topics: Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Electrocardiography; Female; Humans; Male; Middle Aged; Moricizine; Tachycardia, Ventricular | 1993 |
[Pharmacokinetics of moracizine and moracizine sulfoxide in healthy volunteers].
Topics: Adult; Aged; Arrhythmias, Cardiac; Chromatography, High Pressure Liquid; Female; Humans; Male; Middle Aged; Moricizine | 1993 |
[Possibilities of correcting adverse effects of anti-arrhythmia agents].
Topics: Anti-Arrhythmia Agents; Antidepressive Agents; Arrhythmias, Cardiac; Benzamides; Drug Therapy, Combination; Electrocardiography; Electrocardiography, Ambulatory; Moricizine; Morpholines; Myocardial Ischemia; Succinates; Succinic Acid; Tachycardia, Paroxysmal; Ventricular Premature Complexes | 1996 |
A critical appraisal of the cardiac arrhythmia suppression trial (CAST).
Topics: Arrhythmias, Cardiac; Clinical Trials as Topic; Encainide; Flecainide; Humans; Imipramine; Moricizine; Multicenter Studies as Topic; Pilot Projects; Randomized Controlled Trials as Topic; Risk Factors | 1991 |
Characterization of the rate-dependent effects of ethmozine on conduction, in vivo, and on the sodium current, in vitro, in the newborn heart.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Bundle of His; Dogs; Electrophysiology; Heart Conduction System; Heart Ventricles; Moricizine; Myocardium; Sodium; Sodium Channels; Time Factors | 1992 |
A proarrhythmic response to sodium channel blockade: modulation of the vulnerable period in guinea pig ventricular myocardium.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Flecainide; Guinea Pigs; Heart; In Vitro Techniques; Moricizine; Quinidine; Sodium Channels | 1992 |
Induction and termination of afterdepolarizations and triggered arrhythmias by drugs in cat heart in vivo.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cats; Cesium; Chlorides; Electrocardiography; Female; Heart; Lidocaine; Male; Moricizine; Neuromuscular Depolarizing Agents; Phenothiazines; Tachycardia, Supraventricular; Valproic Acid | 1992 |
The effect of pretreatment with moricizine on early arrhythmia resulting from myocardial ischemia in rats.
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Hemodynamics; Male; Mexiletine; Moricizine; Rats; Rats, Inbred Strains | 1992 |
Moricizine hydrochloride (Ethmozine).
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Contraindications; Heart Ventricles; Humans; Moricizine; Tachycardia | 1992 |
[Triggered activities induced by cesium chloride and terminated by drugs in cat heart in vivo].
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cats; Cesium; Chlorides; Female; Lidocaine; Male; Moricizine; Valproic Acid | 1992 |
Efficacy and safety of moricizine in patients with congestive heart failure: a summary of the experience in the United States.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Death, Sudden; Dose-Response Relationship, Drug; Heart Failure; Humans; Moricizine; Phenothiazines; Recurrence; Stroke Volume | 1990 |
The spectrum of CAST I and II.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Death, Sudden, Cardiac; Encainide; Flecainide; Humans; Moricizine; Randomized Controlled Trials as Topic | 1991 |
Efficacy and risks of moricizine in inducible sustained ventricular tachycardia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Evaluation; Electric Stimulation; Electrocardiography; Female; Humans; Male; Middle Aged; Moricizine; Tachycardia | 1992 |
Electrophysiologic response to moricizine in patients with sustained ventricular arrhythmias.
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Drug Evaluation; Electric Stimulation; Electrocardiography; Female; Humans; Male; Middle Aged; Moricizine; Tachycardia; Ventricular Fibrillation | 1992 |
Moricizine (ethmozine HCl)--a new antiarrhythmic drug: is it unique?
Topics: Arrhythmias, Cardiac; Clinical Trials as Topic; Electrophysiology; Heart; Humans; Moricizine | 1991 |
Crime, misdemeanor, and arrhythmia decoding CAST.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Encainide; Flecainide; Heart Ventricles; Humans; Moricizine; Myocardial Infarction; Randomized Controlled Trials as Topic; Research Design; Risk Factors | 1991 |
[Membrane-stabilizing preparations in the treatment of patients with heart rhythm disorders of different etiologies].
Topics: Aconitine; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Drug Evaluation; Electrocardiography; Humans; Middle Aged; Moricizine; Phenothiazines; Remission Induction | 1991 |
The healthy responder phenomenon in non-randomized clinical trials. CAST Investigators.
Topics: Arrhythmias, Cardiac; Clinical Trials as Topic; Data Interpretation, Statistical; Double-Blind Method; Electrocardiography, Ambulatory; Flecainide; Humans; Moricizine; Myocardial Infarction; Randomized Controlled Trials as Topic | 1991 |
Classification of the antiarrhythmic action of moricizine.
Topics: Action Potentials; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Electrophysiology; Humans; Moricizine | 1991 |
New class I antiarrhythmic, moricizine, approved by FDA.
Topics: Arrhythmias, Cardiac; Humans; Moricizine | 1990 |
Moricizine for cardiac arrhythmias.
Topics: Arrhythmias, Cardiac; Clinical Trials as Topic; Drug Interactions; Heart Ventricles; Humans; Moricizine | 1990 |
Overview: moricizine--can it meet the challenge?
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Moricizine; Phenothiazines; Tachycardia | 1990 |
A symposium: Pharmacological management of ventricular arrhythmias--current status in the role of moricizine HCl. October 19-22, 1989, Scottsdale, Arizona. Proceedings.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Moricizine; Phenothiazines; Tachycardia | 1990 |
Placement of moricizine in the selection of antiarrhythmic drug therapy.
Topics: Algorithms; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Moricizine; Phenothiazines | 1990 |
[Long-term use of ethacizin in outpatients with ventricular disorders of heart rhythm].
Topics: Adult; Ambulatory Care; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Drug Evaluation; Drug Tolerance; Electrocardiography; Humans; Middle Aged; Moricizine; Phenothiazines; Tachycardia; Time Factors | 1986 |
[Comparative study of the effectiveness of ethacizine, etmozin and Ritmilen in patients with ventricular rhythmic disorders].
Topics: Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Disopyramide; Drug Evaluation; Electrocardiography; Female; Humans; Male; Middle Aged; Monitoring, Physiologic; Moricizine; Phenothiazines | 1987 |
[Experience with the combined use of 1st- and 2d-group anti-arrhythmic preparations in patients with refractory arrhythmia].
Topics: Aconitine; Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Mexiletine; Middle Aged; Moricizine; Phenothiazines; Propranolol | 1988 |
[Long-term treatment of ventricular arrhythmia caused by electrocardiographic long QT syndrome].
Topics: Arrhythmias, Cardiac; Atropine; Autonomic Nerve Block; Cardiac Complexes, Premature; Child; Combined Modality Therapy; Female; Humans; Lidocaine; Long QT Syndrome; Moricizine; Phenothiazines; Propranolol; Tachycardia, Supraventricular; Time Factors | 1988 |
Prevalence and characteristics of proarrhythmia from moricizine (Ethmozine).
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cross-Sectional Studies; Electrocardiography; Female; Heart Diseases; Humans; Male; Middle Aged; Monitoring, Physiologic; Moricizine; Phenothiazines; Risk Factors; Time Factors | 1989 |
Natural history of potentially lethal ventricular arrhythmias in patients treated with long-term antiarrhythmic drug therapy.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Tolerance; Evaluation Studies as Topic; Humans; Moricizine; Phenothiazines; Placebos; Probability; Time Factors | 1989 |
[A preliminary report on the antiarrhythmic effect of ethmozine].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Female; Humans; Male; Middle Aged; Monitoring, Physiologic; Moricizine; Phenothiazines | 1988 |
Newer antiarrhythmic drugs in children.
Topics: Adolescent; Adult; Amiodarone; Anilides; Arrhythmias, Cardiac; Child; Child, Preschool; Electrocardiography; Encainide; Humans; Infant; Mexiletine; Moricizine; Phenothiazines; Propafenone | 1987 |
[Clinico-pharmacological interactions of digoxin with ethmozine, disopyramide and amiodarone].
Topics: Amiodarone; Arrhythmias, Cardiac; Coronary Disease; Digoxin; Disopyramide; Drug Synergism; Drug Therapy, Combination; Humans; Middle Aged; Moricizine; Phenothiazines | 1988 |
[Effect of ethmozin on the blood circulation system in patients with cardiac rhythm disorders].
Topics: Adult; Aged; Arrhythmias, Cardiac; Coronary Circulation; Hemodynamics; Humans; Middle Aged; Moricizine; Phenothiazines; Work Capacity Evaluation | 1988 |
Ethmozine (moricizine HCl) therapy for complex ventricular arrhythmias.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Administration Schedule; Drug Evaluation; Electrocardiography; Female; Humans; Male; Middle Aged; Monitoring, Physiologic; Moricizine; Phenothiazines | 1987 |
[The antiarrhythmic drug Etmozine in the light of new findings].
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Moricizine; Phenothiazines | 1987 |
[Electrophysiologic research on the anti-arrhythmia properties of bonnecor--a new dibenzazepine derivative].
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cats; Dibenzazepines; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Heart Atria; In Vitro Techniques; Lidocaine; Membrane Potentials; Moricizine; Phenothiazines; Rana esculenta | 1986 |
[Correlation between the anti-arrhythmia effect of ethacizin and pharmacokinetic parameters in a model of rhythm adoption by the heart].
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Biological Availability; Cats; Disease Models, Animal; Drug Evaluation, Preclinical; Half-Life; Kinetics; Moricizine; Phenothiazines; Time Factors | 1986 |
The changing base line of complex ventricular arrhythmias. A new consideration in assessing long-term antiarrhythmic drug therapy.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Female; Humans; Male; Middle Aged; Monitoring, Physiologic; Moricizine; Phenothiazines; Prospective Studies | 1985 |